THE European Medicines
Agency has published a new
2011-15 strategy for combating
antimicrobal resistance, which
encourages an increased level
of innovation on treatment
alternatives for infectious
diseases.
It recommends that authorised
antimicrobials have product
information recommending the
products to be used in a
responsible way and that
pivotal clinical trials should be
conducted according to
“responsible use principles”.
The EMA also said that whilst
off-label usage can be helpful
in some circumstances, such
use may constitute a nonassessed
risk to public health.The above article was sent to subscribers in Pharmacy Daily's issue from 28 Jul 11 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 28 Jul 11
MAYNE Pharma Group Limited has filed a patent infringement suit against Sun Pharmaceutical Industries Ltd and Inc., in the United States District Court, according to yesterday’s ASX announcement.
PHARMACY Connect 2024 conference will feature a provocative ‘Great Debate’ during the Harm Minimisation Workshop on Thu 05 Sep at the Hyatt Regency in Sydney.
LTR Pharma Limited has successfully raised $10.5 million through a share placement to sophisticated and new institutional investors, significantly surpassing initial demand.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.